Hormone Health / TRT / BHRT sourcing for licensed providers.

Hormone optimization practices need formulation flexibility more than they need a single price list. Plativia Labs supports a broad hormone health portfolio across injectable, topical, capsule, troche, sublingual, and other supported dosage forms, matched to your care model, states, volume, and fulfillment requirements.

Dosage forms & formats

  • Injectable vials
  • Topical creams and gels
  • Capsules, troches, and sublingual formats

Built for

TRT and BHRT clinics, men's and women's health practices, anti-aging and functional medicine groups, and multi-state telehealth hormone programs.

Portfolio depth

30

Named products and formulations in this pathway, with more available on request.

Hormone Health / TRT / BHRT portfolio

The right sourcing model depends on the provider's care model, states, volume, formulation needs, and fulfillment requirements.

  • Testosterone Cypionate
  • Testosterone Enanthate
  • Testosterone Cypionate / Enanthate / Propionate
  • Testosterone SR
  • Topical Testosterone
  • Estradiol
  • Estradiol Cypionate
  • Estriol
  • Bi-Est 20:80
  • Bi-Est 50:50
  • Bi-Est + Progesterone
  • Progesterone
  • DHEA
  • Pregnenolone
  • DHEA + Pregnenolone
  • Anastrozole
  • Exemestane
  • Tamoxifen
  • Clomiphene Citrate
  • Enclomiphene Citrate
  • hCG / Chorionic Gonadotropin
  • Gonadorelin
  • Nandrolone / Nandrolone Decanoate
  • Stanozolol
  • Oxandrolone
  • Thyroxine (T4)
  • Liothyronine (T3)
  • T3 / T4 combinations
  • Armour Thyroid
  • Growth hormone, selected commercial products
  • Not listed?Custom sourcing requests for this pathway are reviewed case by case.Ask us

Get pricing on hormone health / trt / bhrt

Send your states, volume, and the formulations you run. We confirm availability and the sourcing pathway, then return pricing and a fulfillment plan.

Request pricing

Qualification

The right sourcing model depends on the provider's care model, states, volume, formulation needs, and fulfillment requirements.

Product and service availability is subject to qualification, applicable law, pharmacy and supplier capability, state eligibility, clinical pathway, and final contracting. Portfolio inclusion does not imply universal availability or suitability, and nothing here constitutes medical advice or a representation that every listed product is available for every use.